Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dapagliflozin at Discharge on Hospital Re-Admissions in Patients With Acutely Decompensated Heart Failure: A Randomized Controlled Study

NCT04249778 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04249778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dapagliflozin at Discharge on Hospital Re-Admissions in Patients With Acutely Decompensated Heart Failure: A Randomized Controlled Study
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
July 29, 2020
Completion date
March 3, 2022
Enrollment
105 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, heart failure